Your browser doesn't support javascript.
loading
Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.
Bliven-Sizemore, E E; Sterling, T R; Shang, N; Benator, D; Schwartzman, K; Reves, R; Drobeniuc, J; Bock, N; Villarino, M E.
Afiliación
  • Bliven-Sizemore EE; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Sterling TR; Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Shang N; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Benator D; Division of Infectious Diseases, Veterans Affairs Medical Center, The George Washington University Medical Center, Washington DC, USA.
  • Schwartzman K; Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, Quebec, Canada.
  • Reves R; Division of Infectious Disease, Department of Medicine, University of Colorado and Denver Health Hospital, Denver, Colorado, USA.
  • Drobeniuc J; Division of Viral Hepatitis, CDC, Atlanta, Georgia, USA.
  • Bock N; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Villarino ME; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Int J Tuberc Lung Dis ; 19(9): 1039-44, i-v, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26260821
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Latente / Enfermedad Hepática Inducida por Sustancias y Drogas / Isoniazida / Antituberculosos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / America do sul / Brasil / Europa Idioma: En Revista: Int J Tuberc Lung Dis Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Latente / Enfermedad Hepática Inducida por Sustancias y Drogas / Isoniazida / Antituberculosos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / America do sul / Brasil / Europa Idioma: En Revista: Int J Tuberc Lung Dis Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos